• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锌在威尔逊病治疗中的作用。

The Role of Zinc in the Treatment of Wilson's Disease.

机构信息

Department of Public Health, School of Medicine, Mashhad University of Medical Sciences, Mashhad 93518-88415, Iran.

2nd Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

出版信息

Int J Mol Sci. 2022 Aug 18;23(16):9316. doi: 10.3390/ijms23169316.

DOI:10.3390/ijms23169316
PMID:36012580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409413/
Abstract

Wilson's disease (WD) is a hereditary disorder of copper metabolism, producing abnormally high levels of non-ceruloplasmin-bound copper, the determinant of the pathogenic process causing brain and hepatic damage and dysfunction. Although the disease is invariably fatal without medication, it is treatable and many of its adverse effects are reversible. Diagnosis is difficult due to the large range and severity of symptoms. A high index of suspicion is required as patients may have only a few of the many possible biomarkers. The genetic prevalence of variants indicates higher rates in the population than are currently diagnosed. Treatments have evolved from chelators that reduce stored copper to zinc, which reduces the toxic levels of circulating non-ceruloplasmin-bound copper. Zinc induces intestinal metallothionein, which blocks copper absorption and increases excretion in the stools, resulting in an improvement in symptoms. Two meta-analyses and several large retrospective studies indicate that zinc is equally effective as chelators for the treatment of WD, with the advantages of a very low level of toxicity and only the minor side effect of gastric disturbance. Zinc is recommended as a first-line treatment for neurological presentations and is gaining acceptance for hepatic presentations. It is universally recommended for lifelong maintenance therapy and for presymptomatic WD.

摘要

威尔逊病(WD)是一种遗传性铜代谢紊乱疾病,导致非铜蓝蛋白结合铜水平异常升高,这是导致脑和肝损伤和功能障碍的致病过程的决定因素。尽管未经药物治疗,该疾病总是致命的,但它是可治疗的,其许多不良反应是可逆转的。由于症状的范围和严重程度很大,因此诊断困难。由于患者可能只有许多可能的生物标志物中的少数几种,因此需要高度怀疑。基因变异的遗传流行率表明,人群中的发病率高于目前的诊断率。治疗方法已经从减少储存铜的螯合剂发展到锌,锌可以降低循环中非铜蓝蛋白结合铜的毒性水平。锌诱导肠金属硫蛋白,阻止铜吸收并增加粪便排泄,从而改善症状。两项荟萃分析和几项大型回顾性研究表明,锌与螯合剂治疗 WD 的效果相当,其优点是毒性水平极低,仅有轻微的胃部不适副作用。锌被推荐作为神经表现的一线治疗药物,并逐渐被接受用于肝脏表现。它被普遍推荐用于终身维持治疗和无症状 WD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57d/9409413/d05a2685c404/ijms-23-09316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57d/9409413/d05a2685c404/ijms-23-09316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57d/9409413/d05a2685c404/ijms-23-09316-g001.jpg

相似文献

1
The Role of Zinc in the Treatment of Wilson's Disease.锌在威尔逊病治疗中的作用。
Int J Mol Sci. 2022 Aug 18;23(16):9316. doi: 10.3390/ijms23169316.
2
Practical recommendations and new therapies for Wilson's disease.威尔逊氏病的实用建议和新疗法
Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004.
3
Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.威尔逊氏病治疗的范式转变:锌疗法现已成为首选治疗方法。
Brain Dev. 2006 Apr;28(3):141-6. doi: 10.1016/j.braindev.2005.08.008. Epub 2006 Feb 7.
4
[The onset of psychiatric disorders and Wilson's disease].[精神疾病与威尔逊氏病的发病]
Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5.
5
Wilson's disease: overview.威尔逊病:概述。
Med Clin (Barc). 2023 Mar 24;160(6):261-267. doi: 10.1016/j.medcli.2022.12.016. Epub 2023 Jan 23.
6
Wilson's disease: A 2017 update.肝豆状核变性:2017 年更新版
Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):512-520. doi: 10.1016/j.clinre.2018.03.007. Epub 2018 Apr 4.
7
[Progress in drug therapy of Wilson's disease].[肝豆状核变性的药物治疗进展]
Zhonghua Gan Zang Bing Za Zhi. 2024 Sep 20;32(9):783-786. doi: 10.3760/cma.j.cn501113-20240714-00324.
8
[The role of zinc in the initial treatment of Wilson's disease in children].[锌在儿童威尔逊病初始治疗中的作用]
Lijec Vjesn. 2000 Mar;122(3-4):77-81.
9
[Pathogenesis and treatment of Wilson's disease].[威尔逊氏病的发病机制与治疗]
Acta Pharm Hung. 2003;73(4):237-41.
10
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.锌疗法可提高威尔逊氏病患者十二指肠中金属硫蛋白和铁的浓度。
Am J Gastroenterol. 1999 Feb;94(2):334-8. doi: 10.1111/j.1572-0241.1999.851_w.x.

引用本文的文献

1
Metals in the human liver: An underappreciated risk factor of hepatic insulin resistance and associated pathophysiology.人体肝脏中的金属:肝脏胰岛素抵抗及相关病理生理学中一个未得到充分认识的危险因素。
Environ Pollut. 2025 Jul 17;383:126844. doi: 10.1016/j.envpol.2025.126844.
2
Rare Movement Disorders-An Approach for Clinicians.罕见运动障碍——临床医生的诊疗方法
Int J Mol Sci. 2025 Jun 23;26(13):6024. doi: 10.3390/ijms26136024.
3
Dietary Zn-Recent Advances in Studies on Its Bioaccessibility and Bioavailability.膳食锌——其生物可及性和生物利用度研究的最新进展

本文引用的文献

1
Acute-Onset Visual Impairment in Wilson's Disease: A Case Report and Literature Review.威尔逊病急性起病的视力损害:一例报告及文献综述
Front Neurol. 2022 Jun 14;13:911882. doi: 10.3389/fneur.2022.911882. eCollection 2022.
2
Long-Term Urinary Copper Excretion and Exchangeable Copper in Children With Wilson Disease Under Chelation Therapy.长期铜排泄和可交换铜在儿童与肝豆状核变性螯合治疗。
J Pediatr Gastroenterol Nutr. 2022 Oct 1;75(4):e75-e80. doi: 10.1097/MPG.0000000000003531. Epub 2022 Jun 16.
3
Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d -penicillamine.
Molecules. 2025 Jun 25;30(13):2742. doi: 10.3390/molecules30132742.
4
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta-analysis of an N-of-1 trial.深部脑刺激治疗与威尔逊病相关的严重肌张力障碍:一项单病例试验的前瞻性多中心荟萃分析。
Eur J Neurol. 2025 Jan;32(1):e16524. doi: 10.1111/ene.16524. Epub 2024 Oct 29.
5
Trientine Tetrahydrochloride, From Bench to Bedside: A Narrative Review.四盐酸曲恩汀,从实验室到临床应用:一篇叙述性综述
Drugs. 2024 Dec;84(12):1509-1518. doi: 10.1007/s40265-024-02099-0. Epub 2024 Oct 17.
6
Mammalian copper homeostasis: physiological roles and molecular mechanisms.哺乳动物的铜稳态:生理作用和分子机制。
Physiol Rev. 2025 Jan 1;105(1):441-491. doi: 10.1152/physrev.00011.2024. Epub 2024 Aug 22.
7
Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease.CRISPR/Cas 景观导航:增强威尔逊病的诊断和治疗。
Cells. 2024 Jul 18;13(14):1214. doi: 10.3390/cells13141214.
8
Zinc Toxicity: Understanding the Limits.锌中毒:了解其限度。
Molecules. 2024 Jul 1;29(13):3130. doi: 10.3390/molecules29133130.
9
ATP-Binding Cassette Transporter of Clinical Significance: Sideroblastic Anemia.具有临床意义的ATP结合盒转运蛋白:铁粒幼细胞贫血
J Pers Med. 2024 Jun 14;14(6):636. doi: 10.3390/jpm14060636.
10
Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury.铜、铁、镉、砷,宇宙中全部生成:阐明其对人类健康包括临床肝损伤的环境影响风险。
Int J Mol Sci. 2024 Jun 17;25(12):6662. doi: 10.3390/ijms25126662.
三乙烯四胺基于螯合剂治疗方案治疗终止二巯丁二酸治疗的肝豆状核变性患者的长期疗效的多中心回顾性研究。
Eur J Gastroenterol Hepatol. 2022 Sep 1;34(9):940-947. doi: 10.1097/MEG.0000000000002387. Epub 2022 Apr 29.
4
Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver.威尔逊病的调查与管理:来自英国肝脏研究协会的实用指南。
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):560-575. doi: 10.1016/S2468-1253(22)00004-8. Epub 2022 Apr 13.
5
Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta-Analysis.青霉胺与锌盐治疗有症状威尔逊病的有效性和安全性比较:一项系统评价和荟萃分析
Front Pharmacol. 2022 Mar 18;13:847436. doi: 10.3389/fphar.2022.847436. eCollection 2022.
6
Cuproptosis: a copper-triggered modality of mitochondrial cell death.铜死亡:一种由铜引发的线粒体细胞死亡方式。
Cell Res. 2022 May;32(5):417-418. doi: 10.1038/s41422-022-00653-7.
7
Copper induces cell death by targeting lipoylated TCA cycle proteins.铜通过靶向脂酰化 TCA 循环蛋白诱导细胞死亡。
Science. 2022 Mar 18;375(6586):1254-1261. doi: 10.1126/science.abf0529. Epub 2022 Mar 17.
8
Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States.威尔逊病:美国商业保险成年人医疗保健利用和费用负担分析。
Hepatol Commun. 2022 Feb;6(2):389-398. doi: 10.1002/hep4.1812. Epub 2021 Sep 2.
9
Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.治疗依从性,即使在可治疗的代谢性罕见病中也是一个挑战:一项对肝豆状核变性的横断面研究。
J Inherit Metab Dis. 2021 Nov;44(6):1481-1488. doi: 10.1002/jimd.12430. Epub 2021 Sep 21.
10
Wilson's disease: update on pathogenesis, biomarkers and treatments.威尔逊病:发病机制、生物标志物和治疗方法的最新进展。
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1053-1061. doi: 10.1136/jnnp-2021-326123. Epub 2021 Aug 2.